SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Moore-Pilon Sandra Jean

(Last)

(First)

(Middle)

C/O RH

15 KOCH ROAD, SUITE K

(Street)

CORTE MADERA

CALIFORNIA

94925

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
10/08/2026

3. Issuer Name and Ticker or Trading Symbol
RH [ RH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SEE REMARKS

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	783	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽¹⁾	06/22/2028	Common Stock	8,000	$151.35	D
Stock Option (Right to Buy)	⁽²⁾	04/28/2030	Common Stock	8,000	$154.82	D
Stock Option (Right to Buy)	⁽³⁾	06/08/2033	Common Stock	5,000	$264.27	D
Stock Option (Right to Buy)	⁽⁴⁾	04/10/2034	Common Stock	5,000	$267.09	D
Stock Option (Right to Buy)	⁽⁵⁾	04/12/2035	Common Stock	10,000	$164.62	D
Stock Option (Right to Buy)	⁽⁶⁾	04/13/2036	Common Stock	20,000	$130.72	D
Stock Option (Right to Buy)	⁽⁷⁾	07/22/2036	Common Stock	40,000	$166.08	D

Explanation of Responses:

1. This option award is fully vested and exercisable.

2. This option award is vested and exercisable with respect to 6,400 of the shares and will vest and become exercisable with respect to an additional 1,600 shares on April 29, 2027, subject to continuous service.

3. This option award is vested and exercisable with respect to 1,500 of the shares and will vest and become exercisable with respect to an additional 750 shares on June 9, 2027, an additional 750 shares on June 9, 2028, an additional 1,000 shares on June 9, 2029, and an additional 1,000 shares on June 9, 2030, subject to continuous service.

4. This option award is vested and exercisable with respect to 1,000 of the shares and will vest and become exercisable with respect to an additional 500 shares on April 11, 2027, an additional 750 shares on April 11, 2028, an additional 750 shares on April 11, 2029, an additional 1,000 shares on April 11, 2030, and an additional 1,000 shares on April 11, 2031, subject to continuous service.

5. This option award is vested and exercisable with respect to 1,429 of the shares and will vest and become exercisable with respect to an additional 1,428 shares on April 13, 2027, an additional 1,429 shares on April 13, 2028, an additional 1,428 shares on April 13, 2029, an additional 1,429 shares on April 13, 2030, an additional 1,428 shares on April 13, 2031, and an additional 1,429 shares on April 13, 2032, subject to continuous service.

6. This option award will vest and become exercisable with respect to 2,000 shares on April 14, 2027, an additional 2,000 shares on April 14, 2028, an additional 2,000 shares on April 14, 2029, an additonal 3,000 shares on April 14, 2030, an additional 3,000 shares on April 14, 2031, and additional 4,000 shares on April 14, 2032, and an additional 4,000 shares on April 14, 2033, subject to continuous service.

7. This option award will vest and become exercisable with respect to 5,715 shares on July 23, 2027, an additional 5,715 shares on July 23, 2028, an additional 5,714 shares on July 23, 2029, an additonal 5,714 shares on July 23, 2030, an additional 5,714 shares on July 23, 2031, and additional 5,714 shares on July 23, 2032, and an additional 5,714 shares on July 23, 2033, subject to continuous service.

Remarks:

Chief Customer Experience & Values Officer

	/s/ Jill Falor, Attorney-in-Fact	10/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)